ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal

doi:10.1186/1475-2867-5-30

Cancer Cell International

Volume 5

Viewing options:

Abstract
Full text
PDF (998KB)

Associated material:

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on PubMed Central
Other articles by authors
on Google Scholar

Choi CH

on PubMed

Choi CH
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Review

ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal

Cheol-Hee Choi

Research Center for Resistant Cells, Chosun University Medical School, 375 Seosuk-dong, Dong-gu, Gwangju 501-759, South Korea

author email corresponding author email

Cancer Cell International 2005, 5:30doi:10.1186/1475-2867-5-30


Published:	4 October 2005

Abstract

One of the major problems related with anticancer chemotherapy is resistance against anticancer drugs. The ATP-binding cassette (ABC) transporters are a family of transporter proteins that are responsible for drug resistance and a low bioavailability of drugs by pumping a variety of drugs out cells at the expense of ATP hydrolysis. One strategy for reversal of the resistance of tumor cells expressing ABC transporters is combined use of anticancer drugs with chemosensitizers. In this review, the physiological functions and structures of ABC transporters, and the development of chemosensitizers are described focusing on well-known proteins including P-glycoprotein, multidrug resistance associated protein, and breast cancer resistance protein.